ILMN vs PFE · rev $4.34B vs P/E 20, rev $15.03B
Illumina Inc (ILMN) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US. It is led by Jacob Thaysen Ph.D..
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla D.V.M., Ph.D..
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. ILMN currently screens at market cap $15.84B.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
ILMN currently screens at market cap $15.84B. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the ILMN and PFE stock pages for the full models.
Not investment advice.